Xlife Sciences AG (SWX:XLS)

Xlife Sciences AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.6	0.4	0.1	0.22	0.22	1.96
Short-Term Investments	0.65	0.65	-	-	-	-
Cash & Short-Term Investments	1.24	1.05	0.1	0.22	0.22	1.96
Cash Growth	2310.61%	961.19%	-54.72%	-1.05%	-88.70%	-58.40%
Accounts Receivable	0.09	0.09	8.46	9.13	0.55	0.28
Other Receivables	0.51	0.37	5.56	8.77	0.41	0.2
Receivables	0.6	0.46	14.02	17.89	0.96	0.48
Inventory	0.03	0.03	0.05	-	-	-
Prepaid Expenses	0.03	0.01	0.04	0.01	0.07	0.03
Other Current Assets	0	-	-	-	-	-0
Total Current Assets	1.9	1.55	14.21	18.12	1.25	2.47
Property, Plant & Equipment	0.69	0.74	0.27	0.39	0.54	0.67
Long-Term Investments	87.1	251.64	245.31	203.01	182.44	156.65
Goodwill	-	-	0.02	0.02	-	-
Other Intangible Assets	245.72	253.68	269.18	285.05	300.91	316.67
Other Long-Term Assets	-0	0	4.44	-0	0	-0
Total Assets	346.75	517.12	540.37	511.99	490.23	480.06

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.47	0.34	1.03	0.97	0.63	0.38
Short-Term Debt	4.33	6.52	5.25	0.84	-	-
Current Portion of Leases	0.11	0.11	0.11	0.11	0.11	-
Current Unearned Revenue	6.44	6.49	2	3.32	0.93	1.68
Other Current Liabilities	1.49	1.46	0.87	0.59	0.27	0.27
Total Current Liabilities	12.84	14.93	9.26	5.83	1.93	2.33
Long-Term Debt	53.55	53.37	53.89	55.57	60.24	62.97
Long-Term Leases	0.52	0.57	0.07	0.18	0.28	0.5
Pension & Post-Retirement Benefits	0.06	0.06	0.06	0.07	0.03	0.11
Long-Term Deferred Tax Liabilities	73.46	75.83	80.57	85.31	90.05	94.94
Other Long-Term Liabilities	-0	0	-	-0	-	0
Total Liabilities	140.43	144.76	143.85	146.96	152.53	160.85

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.77	5.77	5.74	5.59	5.28	5.06
Retained Earnings	-51.33	116.4	137.95	103.67	88.79	74.48
Treasury Stock	-0.01	-1.38	-	-	-	-
Comprehensive Income & Other	168.84	165.74	161.57	158.91	141.16	131.69
Total Common Equity	123.27	286.53	305.26	268.17	235.23	211.23
Minority Interest	83.06	85.83	91.26	96.86	102.47	107.98
Shareholders' Equity	206.32	372.36	396.52	365.04	337.7	319.22
Total Liabilities & Equity	346.75	517.12	540.37	511.99	490.23	480.06

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	58.51	60.57	59.32	56.7	60.63	63.47
Net Cash (Debt)	-57.26	-59.52	-59.22	-56.48	-60.41	-61.51
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-9.96	-10.38	-8.07	-7.80	-8.33	-9.94
Filing Date Shares Outstanding	5.77	5.7	5.74	5.7	5.34	5.28
Total Common Shares Outstanding	5.77	5.7	5.74	5.59	5.28	5.06
Working Capital	-10.95	-13.38	4.95	12.29	-0.68	0.14
Book Value Per Share	21.37	50.25	53.16	47.95	44.52	41.75
Tangible Book Value	-122.46	32.84	36.06	-16.9	-65.68	-105.44
Tangible Book Value Per Share	-21.23	5.76	6.28	-3.02	-12.43	-20.84
Machinery	-	0.26	0.26	0.24	0.23	0.21

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 2, 2026

Data Sources Report a data error